Malickova K - Search Results

1

Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease.

Bortlik M, Duricova D, Malickova K, Machkova N, Bouzkova E, Hrdlicka L, Komarek A, Lukas M. Bortlik M, et al. Among authors: malickova k. J Crohns Colitis. 2013 Oct;7(9):736-43. doi: 10.1016/j.crohns.2012.10.019. Epub 2012 Nov 29. J Crohns Colitis. 2013. PMID: 23200919

2

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.

Bortlik M, Machkova N, Duricova D, Malickova K, Hrdlicka L, Lukas M, Kohout P, Shonova O, Lukas M. Bortlik M, et al. Among authors: malickova k. Scand J Gastroenterol. 2013 Aug;48(8):951-8. doi: 10.3109/00365521.2013.812141. Epub 2013 Jul 8. Scand J Gastroenterol. 2013. PMID: 23834232

3

Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.

Bortlik M, Duricova D, Machkova N, Hruba V, Lukas M, Mitrova K, Romanko I, Bina V, Malickova K, Kolar M, Lukas M. Bortlik M, et al. Among authors: malickova k. Scand J Gastroenterol. 2016;51(2):196-202. doi: 10.3109/00365521.2015.1079924. Epub 2015 Sep 2. Scand J Gastroenterol. 2016. PMID: 26329773

4

Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease.

Malíčková K, Ďuricová D, Bortlík M, Hind'oš M, Machková N, Hrubá V, Lukáš M, Zima T, Lukáš M. Malíčková K, et al. Biologicals. 2016 Jan;44(1):33-6. doi: 10.1016/j.biologicals.2015.09.005. Epub 2015 Oct 23. Biologicals. 2016. PMID: 26603635 Clinical Trial.

5

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.

Farkas K, Rutka M, Golovics PA, Végh Z, Lovász BD, Nyári T, Gecse KB, Kolar M, Bortlik M, Duricova D, Machkova N, Hruba V, Lukas M, Mitrova K, Malickova K, Bálint A, Nagy F, Bor R, Milassin Á, Szepes Z, Palatka K, Lakatos PL, Lukas M, Molnár T. Farkas K, et al. Among authors: malickova k. J Crohns Colitis. 2016 Nov;10(11):1273-1278. doi: 10.1093/ecco-jcc/jjw085. Epub 2016 Apr 21. J Crohns Colitis. 2016. PMID: 27106537 Clinical Trial.

6

Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre.

Kolar M, Duricova D, Bortlik M, Hruba V, Machkova N, Mitrova K, Malickova K, Lukas M Jr, Lukas M. Kolar M, et al. Among authors: malickova k. Dig Dis. 2017;35(1-2):91-100. doi: 10.1159/000453343. Epub 2017 Feb 1. Dig Dis. 2017. PMID: 28147356

7

Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre.

Lukas M, Malickova K, Kolar M, Bortlik M, Vasatko M, Machkova N, Hruba V, Duricova D, Lukas M. Lukas M, et al. Among authors: malickova k. J Crohns Colitis. 2020 Jul 30;14(7):915-919. doi: 10.1093/ecco-jcc/jjaa001. J Crohns Colitis. 2020. PMID: 31905382

8

Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.

Malícková K, Kalousová M, Fucíková T, Bortlík M, Duricová D, Komárek V, Zima T, Janatková I, Lukás M. Malícková K, et al. Scand J Clin Lab Invest. 2010 Jul;70(4):294-9. doi: 10.3109/00365513.2010.485648. Scand J Clin Lab Invest. 2010. PMID: 20446880

9

Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases.

Malíčková K, Duricová D, Bortlík M, Hrušková Z, Svobodová B, Machková N, Komárek V, Fučíková T, Janatková I, Zima T, Lukáš M. Malíčková K, et al. Autoimmune Dis. 2011;2011:945861. doi: 10.4061/2011/945861. Epub 2011 May 29. Autoimmune Dis. 2011. PMID: 21687600 Free PMC article.

10

Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children.

Bortlik M, Duricova D, Machkova N, Kozeluhova J, Kohout P, Hrdlicka L, Durilova M, Mitrova K, Hradsky O, Bronsky J, Malickova K, Lukas M. Bortlik M, et al. Among authors: malickova k. Inflamm Bowel Dis. 2014 Mar;20(3):495-501. doi: 10.1097/01.MIB.0000440984.86659.4f. Inflamm Bowel Dis. 2014. PMID: 24407486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page